MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcimb.2018.00427

Медицинская библиотека · Frontiers in cellular and infection microbiology · 2018

Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.

Marlais Tegwen, Bhattacharyya Tapan, Singh Om Prakash, Mertens Pascal, Gilleman Quentin, Thunissen Caroline, Hinckel Bruno C Bremer, Pearson Callum, Gardner Bathsheba L, Airs Stephanie, de la Roche Marianne, Hayes Kiera, Hafezi Hannah, Falconar Andrew K, Eisa Osama, Saad Alfarazdeg, Khanal Basudha, Bhattarai Narayan Raj, Rijal Suman, Boelaert Marleen, El-Safi Sayda, Sundar Shyam, Miles Michael A

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Background

There is a recognized need for an improved diagnostic test to assess post-chemotherapeutic treatment outcome in visceral leishmaniasis (VL) and to diagnose post kala-azar dermal leishmaniasis (PKDL). We previously demonstrated by ELISA and a prototype novel rapid diagnostic test (RDT), that high anti-Leishmania IgG1 is associated with post-treatment relapse versus cure in VL. Methodology: Here, we further evaluate this novel, low-cost RDT, named VL Sero K-SeT, and ELISA for monitoring IgG1 levels in VL patients after treatment. IgG1 levels against L. donovani lysate were determined. We applied these assays to Indian sera from cured VL at 6 months post treatment as well as to relapse and PKDL patients. Sudanese sera from pre- and post-treatment and relapse were also tested.

Results

Of 104 paired Indian sera taken before and after treatment for VL, when deemed clinically cured, 81 (77.9%) were positive by VL Sero K-SeT before treatment; by 6 months, 68 of these 81 (84.0%) had a negative or reduced RDT test line intensity. ELISAs differed in positivity rate between pre- and post-treatment (p = 0.0162). Twenty eight of 33 (84.8%) Indian samples taken at diagnosis of relapse were RDT positive. A comparison of Indian VL Sero K-SeT data from patients deemed cured and relapsed confirmed that there was a significant difference (p < 0.0001) in positivity rate for the two groups using this RDT. Ten of 17 (58.8%) Sudanese sera went from positive to negative or decreased VL Sero K-SeT at the end of 11-30 days of treatment. Forty nine of 63 (77.8%) PKDL samples from India were positive by VL Sero K-SeT.

Conclusion

We have further shown the relevance of IgG1 in determining clinical status in VL patients. A positive VL Sero K-SeT may also be helpful in supporting diagnosis of PKDL. With further refinement, such as the use of specific antigens, the VL Sero K-SeT and/or IgG1 ELISA may be adjuncts to current VL control programmes.

Для цитирования: Marlais Tegwen, Bhattacharyya Tapan, Singh Om Prakash, Mertens Pascal, Gilleman Quentin, Thunissen Caroline, Hinckel Bruno C Bremer, Pearson Callum, Gardner Bathsheba L, Airs Stephanie, de la Roche Marianne, Hayes Kiera, Hafezi Hannah, Falconar Andrew K, Eisa Osama, Saad Alfarazdeg, Khanal Basudha, Bhattarai Narayan Raj, Rijal Suman, Boelaert Marleen, El-Safi Sayda, Sundar Shyam, Miles Michael A. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.. Frontiers in cellular and infection microbiology. 2018. DOI: 10.3389/fcimb.2018.00427.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.